- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips Electronics results rebound
Philips Electronics reported that steady growth from its components and semiconductors division helped the company report surprisingly strong earnings for its third quarter (end-September). In addition, order intake at the company's medical imaging
Philips Electronics reported that steady growth from its components and semiconductors division helped the company report surprisingly strong earnings for its third quarter (end-September). In addition, order intake at the company's medical imaging business has picked up.
Philips Electronics has recently been plagued by profitability problems, and the company has announced that it intends to restructure some divisions and divest underperforming units in an effort to get back into the black. The company's third-quarter results reflect progress under way at the company: Philips had revenues of $9.7 billion for the quarter and net income of $736 million, compared with revenues of $8.2 billion and net income of $63.3 million in the third quarter of 1996.
Philips said the improved results were due to high demand in its semiconductor business, as well as a turnaround in profitability at its consumer-products division. Exchange-rate differences also helped the company. Philips did not break out results for its Philips Medical Systems business, but it reported that sales in the Professional Products and Systems unit, of which the medical imaging unit is a part, increased 12%, while orders at the unit showed an upward trend in the third quarter.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
